Xiaoli Li

发表

Efficacy of cytarabine, aclarubicin and granulocyte colony-stimulating factor (CAG) regimen compared to FLAG regimen for adult patients with relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.

Depei Wu, Yanming Zhang, Tong Wang, 2015, Leukemia research.

High Tim-3 expression on AML blasts could enhance chemotherapy sensitivity

Depei Wu, J. Yu, Xiaowen Tang, 2017, Oncotarget.

Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: Long-term outcomes of a multicenter study

Shunqing Wang, Depei Wu, Yanming Zhang, 2022, Frontiers in Immunology.

Efficacy of porcine antihuman lymphocyte immunoglobulin compared to rabbit antithymocyte immunoglobulin as a first-line treatment against acquired severe aplastic anemia

Depei Wu, Yanming Zhang, Lian-sheng Zhang, 2015, Annals of Hematology.

Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation

Depei Wu, Xinyou Zhang, Xiao Ma, 2020, Hematology.

Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.

Depei Wu, Yanming Zhang, Qi Qu, 2015, Leukemia research.

Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study

A. Sun, Depei Wu, Xiaowen Tang, 2022, Frontiers in Immunology.

Comparable Outcomes and Health-Related Quality of Life for Severe Aplastic Anemia: Haploidentical Combined With a Single Cord Blood Unit vs Matched Related Transplants

A. Sun, Depei Wu, Xiaowen Tang, 2022, Frontiers in Oncology.

Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.

Depei Wu, Yanming Zhang, Qi Qu, 2015, Leukemia research.

Effectiveness and safety of leukapheresis in hyperleukocytic leukemias: a retrospective multicenter study

Feiran Gong, C. Ruan, Juan Shen, 2022, Leukemia & lymphoma.

Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia.

Depei Wu, Yanming Zhang, Qi Qu, 2015, Leukemia research.

Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis

F. Zhou, Depei Wu, Suning Chen, 2023, Frontiers in Immunology.

Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial

He Huang, Jia Chen, Biqi Zhou, 2024, Signal transduction and targeted therapy.

Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.

Xiaohui Shangguan, Limin Liu, Mei-qing Lei, 2024, Annals of hematology.